- Product Details
Keywords
- 480-19-3
- Isorhamnetin seller in China
- Sell high quality 480-19-3 produced in China factory
Quick Details
- ProName: Isorhamnetin
- CasNo: 480-19-3
- Molecular Formula: C16H12O7
- Appearance: Beige to lighet yellow powder
- Application: FOR RESEARCH USE ONLY
- DeliveryTime: Within 3-7 days after receipt of your ...
- PackAge: As customer request
- Port: QINGDAO CHINA
- ProductionCapacity: 100 Metric Ton/Day
- Purity: 98%min
- Storage: Store in a cool,dry place and keep awa...
- Transportation: Common products:Sea/Air/Courier Dange...
- LimitNum: 100 Metric Ton
Superiority
Details
Details
Isorhamnetin Basic information |
Product Name: | Isorhamnetin |
Synonyms: | 3'-METHOXY-3,4',5,7-TETRAHYDROXYFLAVONE;3'-METHOXY-3,5,7,4'-TETRAHYDROXYFLAVONE;3-METHYLQUERCETIN;3,5,7,4'-TETRAHYDROXY-3'-METHOXYFLAVONE;3,5,7-TRIHYDROXY-2-(4-HYDROXY-3-METHOXYPHENYL)-4-BENZOPYRONE;3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4h-1-benzopyran-4-one;3,5,7-trihydroxy-2-(4-hydroxy-3-metoxyphenyl)benzopyran-4-on;ISOHAMNETIN |
CAS: | 480-19-3 |
MF: | C16H12O7 |
MW: | 316.26 |
EINECS: | 207-545-5 |
Product Categories: | Penta-substituted Flavones;Flavanols;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;Inhibitors |
Mol File: | 480-19-3.mol |
Isorhamnetin Chemical Properties |
mp | 307°C |
storage temp. | 2-8°C |
CAS DataBase Reference | 480-19-3(CAS DataBase Reference) |
Safety Information |
Hazard Codes | Xi,Xn |
Risk Statements | 36/37/38-40 |
Safety Statements | 22-36-26-36/37 |
MSDS Information |
Provider | Language |
---|---|
SigmaAldrich | English |
Isorhamnetin Usage And Synthesis |
Chemical Properties | Beige to lighet yellow powder |
Usage | A metabolite of the flavanoid Quercetin (Q509500) with antioxidant properties. It helps to protect H9c2 cardiomyoblasts against H2O2-induced oxidative stress via the modulation of PI3K/Akt and ERK1/2 signaling pathways. |